Terms: = Liver cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Prognosis
328 results:
1. No Prognostic Impact of Graft-to-Recipient Weight Ratio on Hepatocellular Carcinoma Recurrence Following Living Donor liver Transplantation.
Yang G; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Park GC; Yoon YI; Kang WH; Joo SH; Lee SG
Ann Transplant; 2024 Mar; 29():e942767. PubMed ID: 38439530
[TBL] [Abstract] [Full Text] [Related]
2. Reappraisal of Portal Vein Tumor Thrombosis as a Prognostic Factor for Patients with Hepatocellular Carcinoma.
Chang Y; Yu SJ; Kim HC; Lee YB; Cho EJ; Lee JH; Kim YJ; Chung JW; Yoon JH
Gut Liver; 2024 Jan; 18(1):156-164. PubMed ID: 38013475
[TBL] [Abstract] [Full Text] [Related]
3. prognosis of repeat hepatectomy for liver transplantable hepatocellular carcinoma recurrence after hepatectomy: a Retrospective Cohort Study with the Hiroshima Surgical Study Group of Clinical Oncology (HiSCO).
Ohira M; Kobayashi T; Hamaoka M; Abe T; Onoe T; Inoue M; Honmyo N; Oishi K; Ohdan H;
Langenbecks Arch Surg; 2023 Aug; 408(1):314. PubMed ID: 37584772
[TBL] [Abstract] [Full Text] [Related]
4. Worldwide productivity and research trend of publications concerning tumor immune microenvironment (TIME): a bibliometric study.
Liu YG; Jiang ST; Zhang L; Zheng H; Zhang T; Zhang JW; Zhao HT; Sang XT; Xu YY; Lu X
Eur J Med Res; 2023 Jul; 28(1):229. PubMed ID: 37430294
[TBL] [Abstract] [Full Text] [Related]
5. Regional variation in routes to diagnosis of cholangiocarcinoma in England from 2006 to 2017.
Zalin-Miller A; Jose S; Knott C; Paley L; Tataru D; Morement H; Toledano MB; Khan SA
World J Gastroenterol; 2023 Jun; 29(24):3825-3842. PubMed ID: 37426314
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic impact of R1 resection margin in synchronous and simultaneous colorectal liver metastasis resection: a retrospective cohort study.
Kim NR; Alhothaifi ED; Han DH; Choi JS; Choi GH
World J Surg Oncol; 2023 Jun; 21(1):169. PubMed ID: 37280633
[TBL] [Abstract] [Full Text] [Related]
7. Repeat hepatectomy versus microwave ablation for solitary and small (≤3 cm) recurrent hepatocellular carcinoma with early or late recurrence: A propensity score matched study.
Wang WQ; Lv X; Li J; Li J; Wang JL; Yuan T; Liu JJ; Zhu RH; Huang ZY; Zhang EL
Eur J Surg Oncol; 2023 May; 49(5):1001-1008. PubMed ID: 36585301
[TBL] [Abstract] [Full Text] [Related]
8. Histopathological investigation of colon liver metastases - which factors affect survival after surgery?
Torén W; Sasor A; Ansari D; Andersson R
Scand J Gastroenterol; 2023 Jun; 58(6):627-633. PubMed ID: 36440692
[TBL] [Abstract] [Full Text] [Related]
9. Recent trends in the incidence and survival of stage I liver cancer: a surveillance, epidemiology, and end results analysis.
Yu XC; Liu JB; Tang QH; Diao X; Fan QY; Huang ZY; Tang XM; Li S; Cao YF; Ma YS; Fu D
Ann Med; 2022 Dec; 54(1):2785-2795. PubMed ID: 36370068
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic Impact of Positive Peritoneal Lavage Cytology on Resectable Pancreatic Body and Tail cancer: A Retrospective Study.
Mashiko T; Ogasawara T; Masuoka Y; Ei S; Takahashi S; Hirabayashi K; Mori M; Koyanagi K; Yamamoto S; Nakagohri T
World J Surg; 2023 Mar; 47(3):729-739. PubMed ID: 36357802
[TBL] [Abstract] [Full Text] [Related]
11. Impact of Age of Onset on Survival after Hepatectomy for Patients with Colorectal cancer liver Metastasis: A Real-World Single-Center Experience.
Wang HW; Wang LJ; Jin KM; Bao Q; Li J; Ge SK; Wang K; Xing BC
Curr Oncol; 2022 Nov; 29(11):8456-8467. PubMed ID: 36354726
[TBL] [Abstract] [Full Text] [Related]
12. All-cause and liver-related mortality risk factors in excessive drinkers: Analysis of data from the UK biobank.
Whitfield JB; Seth D; Morgan TR;
Alcohol Clin Exp Res; 2022 Dec; 46(12):2245-2257. PubMed ID: 36317527
[TBL] [Abstract] [Full Text] [Related]
13. Incidence and Survival in Synchronous and Metachronous liver Metastases From Colorectal cancer.
Reboux N; Jooste V; Goungounga J; Robaszkiewicz M; Nousbaum JB; Bouvier AM
JAMA Netw Open; 2022 Oct; 5(10):e2236666. PubMed ID: 36239935
[TBL] [Abstract] [Full Text] [Related]
14. FDG metabolic parameter-based models for predicting recurrence after upfront surgery in synchronous colorectal cancer liver metastasis.
Lee HS; Kwon HW; Lim SB; Kim JC; Yu CS; Hong YS; Kim TW; Oh M; Han S; Oh JH; Park S; Kim TS; Kim SK; Kim HJ; Kwak JY; Oh HS; Kim S; Kwak JM; Lee JS; Kim JS
Eur Radiol; 2023 Mar; 33(3):1746-1756. PubMed ID: 36114846
[TBL] [Abstract] [Full Text] [Related]
15. Lymph Node Ratio Nomogram-Based Prognostic Model for Resected Distal Cholangiocarcinoma.
Perez M; Hansen CP; Burdio F; Pellino G; Pisanu A; Salvia R; Di Martino M; Abu Hilal M; Aldrighetti L; Ielpo B;
J Am Coll Surg; 2022 Nov; 235(5):703-712. PubMed ID: 36102558
[TBL] [Abstract] [Full Text] [Related]
16. Distinct prognosis of biliary tract cancer according to tumor location, stage, and treatment: a population-based study.
Kang MJ; Lim J; Han SS; Park HM; Kim SW; Lee WJ; Woo SM; Kim TH; Won YJ; Park SJ
Sci Rep; 2022 Jun; 12(1):10206. PubMed ID: 35715440
[TBL] [Abstract] [Full Text] [Related]
17. Improved survival of viral hepatocellular carcinoma but not non-viral hepatocellular carcinoma from 2000 to 2020: A multi-centre cohort study of 6007 patients from high-volume academic centres in Japan.
Toyoda H; Kariyama K; Hiraoka A; Tsuji K; Ishikawa T; Hatanaka T; Naganuma A; Yasuda S; Nouso K; Kakizaki S; Kumada T; Innes H; Johnson PJ
Aliment Pharmacol Ther; 2022 Aug; 56(4):694-701. PubMed ID: 35707936
[TBL] [Abstract] [Full Text] [Related]
18. Improved prognosis of hepatitis C-related hepatocellular carcinoma in the era of direct-acting antivirals.
Fukumoto T; Minami T; Moriyama M; Yamada T; Wake T; Kinoshita MN; Fujiwara N; Nakagomi R; Nakatsuka T; Sato M; Enooku K; Nakagawa H; Fujishiro M; Shiina S; Koike K; Tateishi R
Hepatol Commun; 2022 Sep; 6(9):2496-2512. PubMed ID: 35641233
[TBL] [Abstract] [Full Text] [Related]
19. The prognosis of elderly patients with hepatocellular carcinoma: A multi-center 19-year experience in Japan.
Hatanaka T; Kakizaki S; Hiraoka A; Kariyama K; Tsuji K; Ishikawa T; Toyoda H; Yasuda S; Naganuma A; Tada T; Takaguchi K; Tsutsui A; Itobayashi E; Shimada N; Shibata H; Tanaka T; Nagano T; Imai M; Nakamura S; Nouso K; Kosaka H; Kaibori M; Kumada T;
Cancer Med; 2023 Jan; 12(1):345-357. PubMed ID: 35608226
[TBL] [Abstract] [Full Text] [Related]
20. Long-term outcomes of hemostatic therapy for variceal bleeding and the challenge pending in the post-direct-acting antivirals era.
Shibata K; Yokoyama K; Yamauchi R; Matsumoto K; Himeno S; Nagata T; Higashi T; Kitaguchi T; Fukuda H; Tsuchiya N; Fukunaga A; Takata K; Tanaka T; Takeyama Y; Shakado S; Sakisaka S; Hirai F
Acta Gastroenterol Belg; 2022; 85(1):7-14. PubMed ID: 35304988
[TBL] [Abstract] [Full Text] [Related]
[Next]
